增强GmhA抑制剂对格拉姆阴性细菌的活性
François Moreau1, Dmytro Atamanyuk1, Markus Blaukopf2
1Mutabilis, 102 Avenue Gaston Roussel, Romainville 93230, France.
Journal of medicinal chemistry
|April 10, 2024
概括
针对细菌酶GmhA的新型胺酸基抑制剂显示出治疗阳性感染的前景. 这些化合物抑制了脂聚糖合物肝素化,并增强了现有的抗生素.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 抗菌研究 抗菌研究
背景情况:
- 细菌肝素生物合成是新型抗菌疗法的潜在目标.
- 酶GmhA催化了肝素生物合成的第一步,利用其活性位点中的Zn2+离子.
研究的目的:
- 设计和合成针对GmhA酶的新型抑制剂.
- 评估这些化合物对GmhA和细菌生长的抑制潜力和作用机制.
主要方法:
- 酸和酸替代酸衍生物的设计和合成.
- 高分辨率的晶体结构分析与抑制剂复合的GmhA.
- 在体外检测测以确定GmhA抑制,脂多糖肝素化,细胞毒性和抗生素强化.
主要成果:
- 合成和表征了几种酸衍生物.
- 晶体结构证实了抑制剂与GmhA的Zn2+活性位点结合.
- 实现了GmhA的纳米分子抑制;化合物抑制了脂聚糖合物肝素化和*Escherichia coli*中的强化抗生素.
结论:
- 基于酸盐的抑制剂对GmhA和细菌脂聚糖类肝素化是有效的.
- 这些化合物代表了一种有前途的新策略,用于开发对抗格兰氏阴性细菌感染的治疗方法.
- 进一步的发展可能会导致新型抗菌剂用于对抗耐药细菌菌株.
更多相关视频
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
Antimicrobial Proteins
984
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
984
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
312
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
312
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K


